WebinarsNew
Deep DiveNew
Explore Business Standard
Crisil Ratings has revised its outlook on the long-term bank facilities and non-convertible debentures of Metropolis Healthcare Ltd (MHL) to 'positive' from 'stable', while reaffirming its rating at 'Crisil AA-'. The rating agency also reaffirmed its short-term bank facility rating at 'Crisil A1+', according to a note from Crisil Ratings. Crisil said the outlook revision reflects the expected improvement in organic revenue growth, profitability, and cash accruals, along with a meaningful turnaround in its recent acquisition, Core Diagnostics Pvt Ltd. Higher utilisation of the expanded laboratory network, a favourable test mix, and better profitability at Core Diagnostics are expected to support healthy operating margins over the medium term, the agency noted. According to the rating agency, MHL's revenue increased 24 per cent to Rs 1,646 crore in FY26, driven by higher patient volumes and specialised diagnostic and wellness tests under the 'TruHealth' brand. Revenue growth continu
Vedanta Power on Tuesday said rating agency Crisil has upgraded the rating on the company's guaranteed long-term bank facilities, highlighting that the post-demerger structure provides greater strategic focus and enhanced financial flexibility across its businesses. In a statement, the company said Crisil has upgraded Vedanta Power's guaranteed long-term bank facilities to CRISIL AA+ (CE)/Stable from CRISIL AA (CE), while reaffirming its standalone long-term rating at CRISIL AA-/Stable and short-term rating at CRISIL A1+. The rating upgrade follows the successful completion of the Vedanta Group's demerger and reflects Vedanta Power's strengthened credit profile, diversified thermal power portfolio, healthy liquidity position and strategic importance, according to the statement. A CRISIL AA+ (CE) rating means the financial instrument has a high degree of safety regarding timely payment of interest and principal. Crisil also recognised the company's operating performance, long-term .